share_log

3: Initial statement of beneficial ownership of securities-Officer Shah Vinay

SEC ·  Nov 19, 2024 05:05

Summary by Moomoo AI

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    SciSparc
    SPRC
    -- 1.0700
    Unity Biotechnology
    UBX
    -- 1.7800
    BioXcel Therapeutics
    BTAI
    -- 0.573
    Sagimet Biosciences
    SGMT
    -- 6.780
    Vor Biopharma
    VOR
    -- 1.740

    Unlock the Full List